JPS5423966B2 - - Google Patents
Info
- Publication number
- JPS5423966B2 JPS5423966B2 JP11259372A JP11259372A JPS5423966B2 JP S5423966 B2 JPS5423966 B2 JP S5423966B2 JP 11259372 A JP11259372 A JP 11259372A JP 11259372 A JP11259372 A JP 11259372A JP S5423966 B2 JPS5423966 B2 JP S5423966B2
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11259372A JPS5423966B2 (de) | 1972-11-11 | 1972-11-11 | |
| DE2356098A DE2356098C3 (de) | 1972-11-11 | 1973-11-09 | Zusammensetzung für Umschläge |
| GB5221973A GB1450809A (en) | 1972-11-11 | 1973-11-09 | Stupe composition |
| FR7340138A FR2206099B1 (de) | 1972-11-11 | 1973-11-12 | |
| US05/570,429 US4024223A (en) | 1972-11-11 | 1975-04-22 | Stripe composition and method of reducing smell associated therewith |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11259372A JPS5423966B2 (de) | 1972-11-11 | 1972-11-11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS4971132A JPS4971132A (de) | 1974-07-10 |
| JPS5423966B2 true JPS5423966B2 (de) | 1979-08-17 |
Family
ID=14590607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11259372A Expired JPS5423966B2 (de) | 1972-11-11 | 1972-11-11 |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JPS5423966B2 (de) |
| DE (1) | DE2356098C3 (de) |
| FR (1) | FR2206099B1 (de) |
| GB (1) | GB1450809A (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5126217A (ja) * | 1974-08-27 | 1976-03-04 | Riido Kemikaru Kk | Shitsupuzaiyokizai |
| JPS5191318A (ja) * | 1975-02-05 | 1976-08-10 | Shitsupuyakunoseizohoho | |
| HU176217B (en) * | 1978-11-20 | 1981-01-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing a cyclodextrin-chamomille inclusion complex and compositions containing thereof |
| EP0013688B1 (de) * | 1978-12-15 | 1984-02-01 | Kyoshin Co., Ltd. | Riechstoffhaltiges Kunstharzprodukt und Verfahren zur Herstellung dieses Produktes |
| JPS5594316A (en) * | 1979-01-11 | 1980-07-17 | Key Pharma | Diffusion matrix for medicine release |
| JPS5611979A (en) * | 1979-07-12 | 1981-02-05 | Taisho Pharmaceut Co Ltd | Tacky piece |
| JPS5714522A (en) * | 1980-06-09 | 1982-01-25 | Key Pharma | Polymer diffused matrix |
| JPS5920230A (ja) * | 1982-07-19 | 1984-02-01 | チバ−ガイギ−・アクチエンゲゼルシヤフト | ピルプロフエン含有薬剤 |
| FR2539032A1 (fr) * | 1983-01-07 | 1984-07-13 | Heitz Jean | Bande a charge active formee d'argile verte et procede pour sa fabrication |
| JPS6034156A (ja) * | 1983-08-08 | 1985-02-21 | Hayashibara Biochem Lab Inc | エイコサペンタエン酸包接化合物及びこれを含有した飲食物 |
| HU196306B (en) * | 1985-04-01 | 1988-11-28 | Chinoin Gyogyszer Es Vegyeszet | New dusting powders comprising bioactive material and process for preparing the same |
| US4678598A (en) * | 1985-08-06 | 1987-07-07 | Kao Corporation | Liquid shampoo composition |
| HU201685B (en) * | 1987-04-23 | 1990-12-28 | Chinoin Gyogyszer Es Vegyeszet | For producing pharmaceutical compositions for inhalation and compositions for scenting air containing volatile active component in cyclodextrine inclusion, and air-scenting composition |
| GB2307176A (en) * | 1995-11-15 | 1997-05-21 | Todd Selwyn Everest | Anti-inflammatory clathrating agents for topical use |
| FR2898817B1 (fr) * | 2006-03-23 | 2008-08-08 | Univ Rouen | Association de substance oleagineuse avec un melange d'au moins deux cyclodextrines |
-
1972
- 1972-11-11 JP JP11259372A patent/JPS5423966B2/ja not_active Expired
-
1973
- 1973-11-09 GB GB5221973A patent/GB1450809A/en not_active Expired
- 1973-11-09 DE DE2356098A patent/DE2356098C3/de not_active Expired
- 1973-11-12 FR FR7340138A patent/FR2206099B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE2356098B2 (de) | 1978-09-07 |
| DE2356098A1 (de) | 1974-05-30 |
| JPS4971132A (de) | 1974-07-10 |
| DE2356098C3 (de) | 1979-05-03 |
| FR2206099B1 (de) | 1977-01-28 |
| FR2206099A1 (de) | 1974-06-07 |
| GB1450809A (en) | 1976-09-29 |